We did observe some expression of CD16 in CD163+ TAMs, so we cannot rule out the possibility that some of the CD163+ TAMs that co-express CD16 derive from the CD16+ (non-classical & intermediate) monocytes recruited into the tumour. Here, CD163 is linked to neoplasm.